Yahoo
NYSE American - Nasdaq Real Time Price USD

VolitionRx Limited (VNRX)

0.1953 -0.0022 (-1.11%)
At close: October 30 at 4:00:00 PM EDT
0.1919 -0.0034 (-1.74%)
After hours: October 30 at 6:36:20 PM EDT

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Cameron Reynolds MBA
Founder, CEO, President & Director 505.66k -- 1971
Dr. Gaetan Michel Ph.D.
Chief Operating Officer 439.61k -- 1973
Mr. Terig Hughes
CFO & Treasurer 338.74k -- 1970
Dr. Jacob Vincent Micallef MBA, Ph.D.
Chief Scientific Officer 571.55k -- 1956
Mr. Nicholas Plummer
Group General Counsel -- -- 1971
Ms. Louise Batchelor Day
Group Chief Marketing & Communications Officer -- -- 1971
Dr. Jasmine Kway Ph.D.
Chief Revenue Officer -- -- 1972
Mr. Gael Forterre M.B.A.
Chief Licensing Officer -- -- 1981
Mr. Rodney Gerard Rootsaert LLB
Corporate Secretary 126.23k -- 1971

VolitionRx Limited

1489 West Warm Springs Road
Suite 110
Henderson, NV 89014
United States
512 774 8930 https://volition.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
57

Description

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Corporate Governance

VolitionRx Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2026 at 8:00 PM UTC

VolitionRx Limited Earnings Date

Recent Events

October 27, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 25, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 15, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 14, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 9, 2026 at 12:00 AM UTC

S-3/A: Offering Registrations

September 8, 2026 at 12:00 AM UTC

S-3/A: Offering Registrations

September 2, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 28, 2026 at 12:00 AM UTC

S-3: Offering Registrations

August 24, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 21, 2026 at 12:00 AM UTC

S-8: Offering Registrations

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: